FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994916125> ?p ?o ?g. }

• W1994916125 endingPage "199" @default.
• W1994916125 startingPage "191" @default.
• W1994916125 abstract "Five out of six human melanoma cell lines tested were able to degrade in vitro a smooth muscle cell extracellular matrix in a plasmin-dependent way. In three of these five cell lines, this process was mediated by tissue-type plasminogen activator (t-PA) and in the other two cell lines by urokinase-type plasminogen activator (u-PA). All melanoma cell lines produced t-PA mRNA and protein, whereas only the two cell lines showing u-PA-mediated matrix degradation produced u-PA mRNA and protein. These latter cell lines also produced plasminogen activator inhibitor type-1 (PAI-1) and type-2 (PAI-2) mRNA and protein. u-PA receptor (u-PA-R) mRNA and binding of radiolabeled u-PA was found in all melanoma cell lines. The metastatic capacity of these cell lines was studied in nude mice. All cell lines were able to develop primary tumors at the subcutaneous inoculation site. The production of plasminogen activators, their inhibitors and urokinase receptor by subcutaneous tumors corresponded with the production by the parental cell lines in vitro. The two u-PA and PAI-1 producing cell lines showed the highest frequency to form spontaneous lung metastases after subcutaneous inoculation, whereas five of the six cell lines formed lung colonies after intravenous inoculation. In conclusion, u-PA mediated matrix degradation in vitro and production of u-PA and PAI-1 by human melanoma cell lines correlated with their ability to form spontaneous lung metastasis in nude mice. No correlation was found with the ability to form lung colonies after intravenous injection. These findings suggest a role for u-PA and PAI-1 in a relatively early stage of melanoma metastasis." @default.
• W1994916125 created "2016-06-24" @default.
• W1994916125 creator A5011022273 @default.
• W1994916125 creator A5016540821 @default.
• W1994916125 creator A5027507376 @default.
• W1994916125 creator A5027949083 @default.
• W1994916125 creator A5041865031 @default.
• W1994916125 creator A5053003083 @default.
• W1994916125 creator A5056821715 @default.
• W1994916125 date "1991-10-01" @default.
• W1994916125 modified "2023-10-17" @default.
• W1994916125 title "Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation." @default.
• W1994916125 cites W1487780734 @default.
• W1994916125 cites W1495239533 @default.
• W1994916125 cites W1499469957 @default.
• W1994916125 cites W1513691409 @default.
• W1994916125 cites W1548496378 @default.
• W1994916125 cites W1552642838 @default.
• W1994916125 cites W1556949853 @default.
• W1994916125 cites W1558212310 @default.
• W1994916125 cites W1563416335 @default.
• W1994916125 cites W1581591459 @default.
• W1994916125 cites W1584486859 @default.
• W1994916125 cites W1618760884 @default.
• W1994916125 cites W1794257889 @default.
• W1994916125 cites W1822987370 @default.
• W1994916125 cites W1853643611 @default.
• W1994916125 cites W1870102732 @default.
• W1994916125 cites W1965399632 @default.
• W1994916125 cites W1977659044 @default.
• W1994916125 cites W1987299633 @default.
• W1994916125 cites W200635154 @default.
• W1994916125 cites W2014086967 @default.
• W1994916125 cites W2018730365 @default.
• W1994916125 cites W2026707841 @default.
• W1994916125 cites W2028145795 @default.
• W1994916125 cites W2045671747 @default.
• W1994916125 cites W2049631846 @default.
• W1994916125 cites W2056274413 @default.
• W1994916125 cites W2059776541 @default.
• W1994916125 cites W2060138882 @default.
• W1994916125 cites W2062082681 @default.
• W1994916125 cites W2073604224 @default.
• W1994916125 cites W2074352600 @default.
• W1994916125 cites W2077389838 @default.
• W1994916125 cites W2079022749 @default.
• W1994916125 cites W2084949911 @default.
• W1994916125 cites W2089693544 @default.
• W1994916125 cites W2095788196 @default.
• W1994916125 cites W2100607781 @default.
• W1994916125 cites W2115947409 @default.
• W1994916125 cites W2116457807 @default.
• W1994916125 cites W2119837316 @default.
• W1994916125 cites W2121141343 @default.
• W1994916125 cites W2124325733 @default.
• W1994916125 cites W2125311110 @default.
• W1994916125 cites W2134812217 @default.
• W1994916125 cites W2135241184 @default.
• W1994916125 cites W2142633589 @default.
• W1994916125 cites W2143067833 @default.
• W1994916125 cites W2154671319 @default.
• W1994916125 cites W2297706864 @default.
• W1994916125 cites W23122061 @default.
• W1994916125 cites W2395233534 @default.
• W1994916125 cites W2400166575 @default.
• W1994916125 cites W2415114669 @default.
• W1994916125 cites W2416137557 @default.
• W1994916125 cites W2471368982 @default.
• W1994916125 cites W2472331521 @default.
• W1994916125 cites W281257934 @default.
• W1994916125 cites W286393150 @default.
• W1994916125 cites W45293395 @default.
• W1994916125 cites W60985570 @default.
• W1994916125 doi "https://doi.org/10.1083/jcb.115.1.191" @default.
• W1994916125 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2289921" @default.
• W1994916125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1918136" @default.
• W1994916125 hasPublicationYear "1991" @default.
• W1994916125 type Work @default.
• W1994916125 sameAs 1994916125 @default.
• W1994916125 citedByCount "149" @default.
• W1994916125 countsByYear W19949161252012 @default.
• W1994916125 countsByYear W19949161252013 @default.
• W1994916125 countsByYear W19949161252014 @default.
• W1994916125 countsByYear W19949161252015 @default.
• W1994916125 countsByYear W19949161252016 @default.
• W1994916125 countsByYear W19949161252017 @default.
• W1994916125 countsByYear W19949161252018 @default.
• W1994916125 countsByYear W19949161252020 @default.
• W1994916125 countsByYear W19949161252021 @default.
• W1994916125 crossrefType "journal-article" @default.
• W1994916125 hasAuthorship W1994916125A5011022273 @default.
• W1994916125 hasAuthorship W1994916125A5016540821 @default.
• W1994916125 hasAuthorship W1994916125A5027507376 @default.
• W1994916125 hasAuthorship W1994916125A5027949083 @default.
• W1994916125 hasAuthorship W1994916125A5041865031 @default.
• W1994916125 hasAuthorship W1994916125A5053003083 @default.
• W1994916125 hasAuthorship W1994916125A5056821715 @default.
• W1994916125 hasBestOaLocation W19949161251 @default.

• next